Search Results

3D BioFibR produces naturally sourced, high value biofibers, such as collagen and spider silk, for potential use in biomedical engineering, green textiles, defense, and aerospace applications.

Syntplant sp. z o.o. uses materials and technologies it has developed to produce implants based on bioresorbable materials, including innovative bone-forming filaments customized to the individual patient's needs. Our products are used wherever there is a need to supplement bone loss. The implants we manufacture take advantage of the body's natural ability to regenerate.

Essent Biologics is a nonprofit biotechnology company setting a new standard in human-derived biomaterials and comprehensive data for research.

Mycorena is a Swedish company that produces food products by using filamentous fungi in a fermentation process. At Mycorena, we are staunch believers in the amazing potential and power of filamentous fungi. Judging by the high global levels of activity within the entire intellectual property space, we are not alone.

We are the first company in Korea to work on developing bioink that combine human-derived collagen/human-derived extracellular matrices with hydrogels.

We imagined a future where no cow, pig, chicken or other animal needs to be harmed to satisfy our needs. We imagined what the world would look like if animals were subtracted from the equation entirely. It didn't take long for us to conclude that this was still a far-away fantasy; there were still too many things that too many of us would miss. Existing, innovative alternatives could satisfy our yearning for obvious products like meat and dairy, but substitutes are lacking for the hard-to-replace by-products of the meat and dairy industry; the smaller parts that are so very important, but far too often overlooked. 

Using our expertise, understanding, and focus on the biological needs of cells in 3D biprinted constructs, we have created a novel bioink capable of printing hiPSC-derived neural cells that maintain high levels of cell viability for over a month.

BIOFABICS is an R&D company specialized in the generation and culture of 3D Biotissue Analogues

Founded in 2016, BICO (formerly CELLINK) is the leading bio convergence company in the world. By combining different technologies, such as robotics, artificial intelligence, computer science, and 3D bioprinting with biology, we enable our customers to improve people's health and lives for the better.

Viscofan BioEngineering is a business unit of Naturin Viscofan GmbH – a company of the Viscofan group. The modern production facilities including a plant for medical grade production are located in Weinheim, Germany. A dedicated international team covers the complete value chain from research to development and sales of novel collagen products.

We develop industrial solutions for the production of plant- or cell-based animal protein analogues (mimetic food) using 2D/3D laser printing, bioprinting and robotics.

The jellyfish collagen-based innovation addresses complex regenerative medical needs, shaping next-generation treatments and supporting current and future scientific research. At the heart of products is marine-sourced Collagen Type 0, evolutionary ancient stem collagen that is foundational, allowing greater applications across multiple indications.

Rousselot is the global leader in collagen-based solutions for the food, health & nutrition, biomedical, and pharmaceutical sectors.

The project Chiron is part of Eurostar, a european programme to foster R&D and international collaboration between companies and research institutes to create innovative products and technologies. Chiron is an international collaboration between two SMEs (Concr3de BV and IPC,Innovative Polymer Compounds) and two research centers (University Medical Center of Utrecht and the Trinity College of Dublin). The aim of the project is to create a fast multimaterial bioprinting platform for the research and production in the biomedical sector to create a portfolio of biomaterials and applications of the technology.

4D Biomaterials is the trading name of 4D Medicine Ltd, a company that was spun out from the Universities of Birmingham and Warwick in April 2020.

At XPECT-INX, we are focusing on the commercialisation of materials and bioinks for 3D bioprinting by utilizing decades of academic experience in the field of polymers and biomaterials.

Humabiologics, Inc is a regenerative medicine startup founded by scientists and tissue industry experts with scientific, quality, regulatory and technology transfer expertise to address the gap between the gift of donated human tissues and researchers. Currently, the availability of human-derived biomaterials for regenerative therapies and research is limited due to unstable supply channels, low quality, and high prices. Humabiologics is dedicated to extending the gift of donation by developing and commercializing high quality, supply-stable and affordable human-derived biomaterials from tissue and organs for regenerative medicine therapies that complies with the FDA's 21 CFR 1271 regulation and the tissue industry quality system standards. By stretching the gift of donation we strive to help as many people as possible with our unique product.

Allegro 3D is an emerging 3D printing and bioprinting company located in San Diego, a world hub for biotechnology. At the convergence of advanced additive manufacturing, stem cell biology and biomaterials, Allegro 3D’s expertise in bioprinting and biomaterials enables high-throughput manufacturing of advanced biomedical devices, cell matrices and precision human tissues for cell culture, drug screening, therapeutics and regenerative medicine.

Foldink® is a Biotechnology startup which provides 3D Bioprinting technology to biomedical scientists who are conducting research in tissue engineering and regenerative medicine.

Axolotl Biosystems creates high-resolution desktop 3D bioprinters and bioinks capable of producing functional three dimensional living tissues. Built to reduce the high costs of traditional 3D bioprinting systems, the accessibility to researchers and flexible open system architecture for construct design is making Axolotl Biosystems products the platform of choice for leading bioengineering laboratories around the world.